Understanding the Secondary Use of Clinical Trial Data: perspectives from patients, clinicians, industry, and regulators
We are delighted to invite you to the II LET’s FACILITATE 2024 Webinar, an engaging exploration and roundtable discussion centered around the FACILITATE project and the perspectives of various stakeholders involved in clinical trials. This session will focus on the importance of the secondary use of data collected during these trials.Understanding the Secondary Use of Clinical Trial Data: perspectives from patients, clinicians, industry, and regulators
Register [HERE] to secure your spot.
Date: December 11, 2024
Time: 2:30 to 4:00 p.m. CET
What distinguishes this session is the diverse range of perspectives from key stakeholders. Alongside patient testimonials, we will hear insights from clinicians, representatives from industry, and regulatory bodies. This inclusive panel ensures a holistic discussion that fosters collaboration among all involved.
Agenda
Moderator: Nuala Ryan, Takeda, Public Private Partnership Team, Clinical Research Consultant and Patient Advocate
- 2:30-2:35 Opening Session:
Jean Sposaro: Director, Bristol Myers Squibb Global Industry | Human Advocate for Equity in Access and Informed Decision Making - 2:35 – 2:45 Progress Overview:
Johanna Blom: Professor of Psychobiology Pediatric & Behavioral Neuroscience, University of Modena, and IHI FACILITATE Coordinator - 2:45: 2:50 Q&A
- 2:50 –3:45: Stakeholder Virtual Roundtable:
Panellists:- Daniel Theisen, patients’ representative, Director of ALAN – Maladies Rares Luxembourg
- Ana Vieira, patient, Sjögren Europe co-founder & board member, Portugal
- Paweł Wrona, Neurology Specialist, Investigator, Clinical Research Manager, Jagiellonian University Medical College, Poland
- Manuel Franco-Martin, Director of the Research Group of Institute of Biomedicine of Salamanca (IBSAL), Spain.
- Rebecca Sudlow, Data Privacy and Sharing Enabling Platform Leader, Roche UK
- Aaron Mann, CEO of the Clinical Research Data Sharing Alliance, USA
- 3:45-4:00 Q&A
Discussion Topic:
- Each panelist will discuss why the “FACILITATE” secondary use of clinical trial data is important to them and share the potential impact it would have on their lives or work
- + the main challenges they see.
Ideal attendees:
This webinar is perfect for anyone interested in or involved with clinical trials and data management, including patients and their associations, clinicians, investigators, nurses, the pharma industry, Health Authorities and Regulatory Agencies, Clinical Research Organizations (CROs), and more.
FACILITATE webinar will be recorded.
We eagerly anticipate your participation in this enriching discussion
